{{Rsnum
|rsid=11038689
|Gene=CRY2
|Chromosome=11
|position=45852713
|Orientation=plus
|GMAF=0.1538
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CRY2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 61.1 | 31.0 | 8.0
| HCB | 80.3 | 18.2 | 1.5
| JPT | 71.7 | 27.4 | 0.9
| YRI | 78.9 | 19.7 | 1.4
| ASW | 73.7 | 26.3 | 0.0
| CHB | 80.3 | 18.2 | 1.5
| CHD | 72.5 | 26.6 | 0.9
| GIH | 77.2 | 18.8 | 4.0
| LWK | 82.7 | 16.4 | 0.9
| MEX | 81.0 | 17.2 | 1.7
| MKK | 71.2 | 26.9 | 1.9
| TSI | 54.9 | 41.2 | 3.9
| HapMapRevision=28
}}{{PMID|19318546|OA=1
}} Clock-Cancer Connection in [[Non-Hodgkin's Lymphoma]]
*[[rs11038689]], OR, 2.34 (1.28-4.27), P = 0.006); 
*[[rs7123390]], OR, 2.40 (1.39-4.13), P = 0.002); 
*[[rs1401417]], OR, 2.97 (1.57-5.63, P = 0.001)

{{PMID Auto
|PMID=20233903
|Title=The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}